Real-world frequency and outcomes of intraocular inflammation-related adverse events in eyes with neovascular age-related macular degeneration treated with brolucizumab

被引：0
|
作者：
Mccoy, Jasmyne E. [1 ]
Zubricky, Ryan [2 ]
Donkor, Richard [1 ]
Miller, David G. [1 ]
Sonbolian, Nina [3 ]
Heaney, Andrew [3 ]
Bilano, Ver [3 ]
Karcher, Helene [3 ]
Coney, Joseph M. [1 ]
机构：
[1] Retina Associates Cleveland Inc, Beachwood, OH USA
[2] Geisinger Med Ctr, Danville, PA USA
[3] Novartis AG, Basel, Basel Stadt, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2216
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
    Zubricky, Ryan
    McCoy, Jasmyne
    Donkor, Richard
    Miller, David G.
    Sonbolian, Nina
    Heaney, Andrew
    Bilano, Ver
    Karcher, Helene
    Coney, Joseph M.
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2397 - 2408
  • [2] Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
    Ryan Zubricky
    Jasmyne McCoy
    Richard Donkor
    David G. Miller
    Nina Sonbolian
    Andrew Heaney
    Ver Bilano
    Helene Karcher
    Joseph M. Coney
    Ophthalmology and Therapy, 2023, 12 : 2397 - 2408
  • [3] Real-world outcomes for fellow eyes in neovascular age-related macular degeneration
    Aydogmus, Fatma Sema Akkan
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Lasalle, Claudia
    Ramsey, David J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [4] Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab
    Hashimoto, Yuto
    Inoda, Satoru
    Takahashi, Hidenori
    Takahashi, Ryota
    Yoshida, Hana
    Fujino, Yujiro
    Sakamoto, Shinichi
    Kawashima, Hidetoshi
    Yanagi, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (01)
  • [5] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Zarbin, Marco A.
    MacCumber, Mathew W.
    Karcher, Helene
    Adiguzel, Eser
    Mayhook, Andrew
    LaPrise, Andrew
    Bilano, Ver L.
    Igwe, Franklin
    Ip, Michael S.
    Wykoff, Charles C.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1357 - 1368
  • [6] Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study
    Chakraborty, Debdulal
    Maiti, Aniruddha
    Sheth, Jay U.
    Boral, Subhendu
    Mondal, Soumen
    Nandi, Krishnendu
    Sinha, Tushar
    Das, Arnab
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 3787 - 3795
  • [7] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Marco A. Zarbin
    Mathew W. MacCumber
    Helene Karcher
    Eser Adiguzel
    Andrew Mayhook
    Andrew LaPrise
    Ver L. Bilano
    Franklin Igwe
    Michael S. Ip
    Charles C. Wykoff
    Ophthalmology and Therapy, 2024, 13 : 1357 - 1368
  • [8] Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands
    Verbraak, Frank D.
    Ponsioen, Dirk L.
    Tigchelaar-Besling, Odette A. M.
    Nguyen, Vuong
    Gillies, Mark C.
    Barthelmes, Daniel
    Klaver, Caroline C. W.
    ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E884 - E892
  • [9] Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration
    Hirono, Kazushi
    Maruyama-Inoue, Maiko
    Yanagi, Yasuo
    Kadonosono, Kazuaki
    PLOS ONE, 2024, 19 (04):
  • [10] Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson L.
    Aydogmus, Fatma Sema Akkan
    Lasalle, Claudia C.
    Ramsey, David J.
    LIFE-BASEL, 2023, 13 (02):
12345